Tuesday, June 22, 2010

Baxano Raises $30M

San jose-based Baxano, a developer of medical devices for treatment of spinal disorders, has raised $30M in a Series C funding, the firm has announced. The funding was led by CMEA Capital, and also included Kaiser Permanente ventures, Affinity Capital Management, Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners. The firm said the funding will go towards its US commercial launch, and an additional post-clearance clinical study of its products. More information »